B.Riley/FBR analyst Mayank Mamtani raised the price target on Novavax (NASDAQ: NVAX) to $53.00 (from $43.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE